← Evidence map

ReviewTherapeutic advances in medical oncology2022

Brief overview: cemiplimab for the treatment of advanced basal cell carcinoma: PD-1 strikes again.

Christina M Davis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

24 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35082923